| Patent | Date |
|---|
Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
Grant 8,883,798 - Jansa , et al. November 11, 2 | 2014-11-11 |
Pyrimidine Compounds Inhibiting The Formation Of Nitric Oxide And Prostaglandin E2, Method Of Production Thereof And Use Thereof
App 20130324566 - Jansa; Petr ; et al. | 2013-12-05 |
Azacytosine derivatives useful as antiviral agents
Grant 8,153,787 - Holy , et al. April 10, 2 | 2012-04-10 |
Azacytosine Derivatives Useful as Antiviral Agents
App 20090005346 - Holy; Antonin ; et al. | 2009-01-01 |
Novel compounds and methods for therapy
App 20060241081 - Balzarini; Jan M. R. ; et al. | 2006-10-26 |
Phosphonate substituted pyrimidine compounds and methods for therapy
Grant 7,115,592 - Balzarini , et al. October 3, 2 | 2006-10-03 |
Novel compounds and methods for therapy
App 20050075318 - Balzarini, Jan M.R. ; et al. | 2005-04-07 |
Novel compounds and methods for therapy
App 20050038058 - Balzarini, Jan M. R. ; et al. | 2005-02-17 |
Antiviral compounds and methods for synthesis and therapy
Grant 6,818,633 - Balzarini , et al. November 16, 2 | 2004-11-16 |
Antiretroviral enantiomeric nucleotide analogs
Grant 6,653,296 - Holy , et al. November 25, 2 | 2003-11-25 |
Novel compounds and methods for therapy
App 20030109499 - Balzarini, Jan M. R. ; et al. | 2003-06-12 |
Antiretroviral enantiomeric nucleotide analogs
Grant 6,057,305 - May 2, 2 | 2000-05-02 |
N.sup.6 - substituted nucleotide analagues and their use
Grant 5,977,061 - Holy , et al. November 2, 1 | 1999-11-02 |
9-(2-phosphonylmethoxyethyl) guanine
Grant 5,869,467 - Holy , et al. February 9, 1 | 1999-02-09 |
N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
Grant 5,733,896 - March 31, 1 | 1998-03-31 |
N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity
Grant 5,641,763 - Holy , et al. June 24, 1 | 1997-06-24 |
Di(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-P-to-luenesulfonyloxypropanes, their producing and utilization
Grant 5,352,786 - Jindrich , et al. October 4, 1 | 1994-10-04 |
N-phosphonylmethoxyalkyl derivatives of pyrimidine and purine bases and a therapeutical composition therefrom with antiviral activity
Grant 5,142,051 - Holy , et al. August 25, 1 | 1992-08-25 |
(2R)-2-[di(2-propyl)phosphonylmethoxy]-3-p-to luenesulfonyloxy-1-trimethylacetoxypropane, its preparation and use
Grant 5,130,427 - Alexander , et al. July 14, 1 | 1992-07-14 |
9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereof
Grant 4,808,716 - Holy , et al. February 28, 1 | 1989-02-28 |
Therapeutical application of phosphonylmethoxyalkyl adenines
Grant 4,724,233 - De Clercq , et al. February 9, 1 | 1988-02-09 |
Isomeric O-phosphonylmethyl derivatives of enantiomeric and racemic 9-(2,3-dihydroxypropyl)adenine
Grant 4,659,825 - Holy , et al. April 21, 1 | 1987-04-21 |
Antivirally active adenine derivatives
Grant 4,605,658 - Holy , et al. August 12, 1 | 1986-08-12 |
Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
Grant 4,230,708 - De Clercq , et al. October 28, 1 | 1980-10-28 |
| 